Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.Jacob Kaufman, David P. Carbone, Carolyn J. Presley et al.|Journal of Clinical Oncology|2023Cited by 1